Free Health Updates
Skip to main content
Table of Contents
< All Topics
Print

What Research Supports Cannabis Use in OCD? 

Posted
Updated
ByMy Patient Advice
Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

Exploring OCD and cannabis research provides insight into the potential therapeutic role of cannabis for patients with obsessive-compulsive disorder. While data is still emerging, studies suggest that cannabinoids may influence anxiety, compulsive behaviours, and stress responses, offering a complementary approach to traditional treatments. 

Book Consultation for Medical Cannabis

Current Evidence on OCD and Cannabis 

Reviewing OCD and cannabis research helps clarify potential benefits, limitations, and directions for further study. 

Scientific Studies on OCD and Cannabis 

Several scientific studies on OCD and cannabis indicate that cannabinoids can reduce anxiety and compulsive behaviours in some patients, though findings are preliminary and require replication. 

Medical Marijuana Evidence for OCD 

Medical marijuana evidence for OCD includes patient reports and observational studies suggesting improvements in mood, intrusive thoughts, and daily functioning with controlled cannabis use. 

Clinical Trials on OCD 

Ongoing clinical trials on OCD aim to evaluate efficacy, dosage, and safety of cannabis, providing more robust data to support clinical decision-making. 

Practical Implications 

Patients considering treatment based on OCD and cannabis research should consult healthcare professionals to integrate findings safely with conventional therapies. 

While OCD and cannabis research is promising, comprehensive trials are needed to establish clear guidelines for clinical use and patient safety. 

If you’re exploring cannabis treatment options for obsessive-compulsive disorder, visit providers like LeafEase for personalised consultations and guidance tailored to your needs. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Obsessive-Compulsive Disorder.

Julia Sutton, MSc
Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Dr. Clarissa Morton, PharmD
Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy. 

Categories